Replimune Group, Inc.

REPL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Feb 12, 2025 10-Q
8-K Feb 12, 2025 FORM 8-K
CORRESP Feb 10, 2025
SCHEDULE 13G/A Jan 31, 2025
UPLOAD Jan 27, 2025
8-K Jan 22, 2025 FORM 8-K
S-8 Jan 17, 2025 FORM S-8
S-8 Dec 20, 2024 FORM S-8
4 Dec 18, 2024 OWNERSHIP DOCUMENT
144 Dec 16, 2024
8-K/A Dec 4, 2024 FORM 8-K/A
8-K Nov 27, 2024 FORM 8-K
424B5 Nov 26, 2024 424B5
8-K Nov 26, 2024 FORM 8-K
424B5 Nov 25, 2024 424B5
8-K Nov 21, 2024 FORM 8-K
4 Nov 20, 2024 OWNERSHIP DOCUMENT
4 Nov 20, 2024 OWNERSHIP DOCUMENT
S-8 Nov 19, 2024 FORM S-8
SC 13G/A Nov 14, 2024 SC 13G/A
SC 13G/A Nov 14, 2024
SC 13G/A Nov 14, 2024 SC 13G/A
SC 13G/A Nov 14, 2024 SC 13G/A
SC 13G/A Nov 12, 2024
10-Q Nov 12, 2024 10-Q
← Newer Page 7 of 27 · 669 filings Older →